Distinguishing the Healthcare Market from Conventional Markets

Ever wonder why you can’t shop for a surgery the same way you shop for a new smartphone? In a regular market, you can compare prices, read reviews, and check features. But when it comes to healthcare, the entire experience is different. It’s often confusing, the prices are hidden, and you’re usually relying on one expert (your doctor) to tell you what you need. This isn’t an accident. The market for healthcare is fundamentally different from the ‘conventional’ markets we interact with every day. It’s a unique economic puzzle, filled with complexities that economists call ‘market failures.’ Understanding these differences is the key to understanding why healthcare systems around the world are structured the way they are, with such a heavy-handed role for governments and regulations.

What does a ‘conventional’ market look like? 🔗

Before we dive into what makes healthcare special, let’s paint a quick picture of a ‘perfect’ conventional market, the kind you read about in an economics 101 textbook. This ideal market-think of a large, bustling farmers’ market-has a few key ingredients:

• Numerous producers and consumers: Lots of farmers are selling tomatoes, and lots of people are buying them. No single farmer or buyer can set the price.
• Informed consumers: You can see the tomatoes, feel them, and compare the price from one stall to the next. You have all the information you need to make a good choice.
• Consumer sovereignty: You are the king. If you decide you want more organic tomatoes and fewer conventional ones, the market will respond. Producers will start growing more organic tomatoes.
• Fair income distribution: This is a big assumption, but the ideal market assumes everyone has the basic ability to pay for the goods they need.
• No ‘externalities’: Your decision to buy a tomato doesn’t really affect anyone else. The transaction is just between you and the farmer.

When all these conditions are met, the market is incredibly efficient. But when one or more of them break down, we get what economists call market failure. And as we’re about to see, the healthcare market is practically a textbook example of every single one of these conditions failing to hold true. As the World Health Organization (WHO) points out, health markets are different because of the uncertainty of needing care, the high costs, and the complex information involved.

The problem of scale in healthcare 🔗

One of the first big differences is scale. In many industries, the bigger your operation, the lower your per-unit cost. This is called economies of scale. Think about a car factory: the first car is incredibly expensive to build (you need the factory, the robots, the design), but the millionth car is relatively cheap.

Healthcare is an industry that often requires massive scale to be efficient. A modern hospital needs millions of dollars in equipment, like MRI machines and surgical suites, and a large, specialized staff. A small, private clinic simply cannot afford this level of infrastructure. If a private hospital wants to serve a small, wealthy neighborhood, it might not have enough patients to make that MRI machine economical. The machine might sit unused most of the time, forcing the hospital to charge astronomical prices for each scan to cover the cost.

This is precisely why government often steps in. A government-run health program isn’t just serving one neighborhood; it’s serving an entire city, state, or country. By pooling the entire population, it can achieve a massive scale that no private player can match. This scale allows it to build the big hospitals, buy the expensive equipment, and run public health campaigns, all while keeping the *average cost per person* much lower.

Good examples include England’s National Health Service (NHS) or, closer to home, India’s National Health Mission (NHM). The NHM’s entire purpose is to provide accessible, affordable, and quality healthcare to a vast population, especially in rural areas. A project of this magnitude, aiming to cover hundreds of millions of people, is only feasible through a large-scale, coordinated public effort that leverages the principles of public health at a national level.

Medicine, monopolies, and missing welfare 🔗

In our perfect farmers’ market, there are dozens of sellers. In healthcare, you often face a monopoly. This isn’t usually one giant company that owns everything, but rather a series of smaller, powerful monopolies.

The power of patents 🔗

First, think about prescription drugs. When a company invents a new life-saving drug, it receives a patent. This patent gives the company the exclusive right to sell that drug for many years. This is a deliberate, government-granted monopoly. The idea is to incentivize innovation; without the promise of monopoly profits, companies might not spend the billions needed for research and development (R&D).

But this creates a major problem. As the World Trade Organization (WTO) acknowledges in its framework on intellectual property (TRIPS), there’s a difficult balance between rewarding innovation and ensuring public access. The monopoly holder can charge a very high price, making the drug unaffordable for many who need it. Economically, this means the ‘output’ (the number of people who get the drug) is lower than the socially optimal level, and the high price creates what’s called a deadweight welfare loss-a loss to society because beneficial trades (a sick person getting a drug) aren’t happening.

The power of licenses 🔗

It’s not just drugs. The professions themselves are restricted. You can’t just declare yourself a doctor or a surgeon. You need to go through years of schooling and, critically, get a license from a medical board. This licensing system is crucial for ensuring quality and safety-you *want* to know your surgeon is qualified! But economically, it has the same effect as a monopoly: it restricts the supply of producers (doctors). With a limited supply of doctors, their services become more expensive, and wait times can grow longer.

Can price controls help? 🔗

When a monopoly is charging too much, a common (though controversial) government response is a price ceiling-a legal maximum price. For example, a government might cap the price of a patented cancer drug. In a normal competitive market, price ceilings are disastrous, leading to massive shortages. But with a monopoly, a price ceiling can *theoretically* have a positive effect. If the price is set below the monopoly price but still above the cost of production, it can force the monopolist to sell *more* of the product at a *lower* price, reducing that deadweight loss and getting the medicine to more people.

[Image: Diagram showing welfare loss from monopoly and the effect of a price ceiling]

Is health a public good or a merit good? 🔗

This is another key distinction. People often call healthcare a “public good,” but in strict economic terms, it usually isn’t. Let’s clarify.

A true public good has two specific characteristics:

1. Non-rivalrous: My consumption of it doesn’t stop you from consuming it. (Example: A broadcast radio signal.)
2. Non-excludable: I can’t stop you from consuming it, even if you don’t pay. (Example: National defense.)

Is a doctor’s visit a public good? No.

• It’s rivalrous: If the doctor is seeing me, she cannot see you at the same time.
• It’s excludable: A private hospital can (and will) deny you service if you don’t pay.

Instead, healthcare is what economists call a merit good. This is a private good that society believes is so beneficial that everyone should have some basic level of it, regardless of their ability to pay. Education and public housing are other classic examples. We, as a society, believe everyone deserves to be healthy, so we often intervene to provide it.

Where are the public goods in health? 🔗

While the *service* of healthcare is a private or merit good, some crucial *components* of the health system are public goods.

The most important one is information. Public health knowledge-like “smoking causes cancer” or “washing hands prevents disease”-is a true public good. It’s non-rivalrous (we can all know it) and non-excludable. The problem with public goods is that the private market will always *under-produce* them. No private company has a profit motive to run a “wash your hands” campaign. This is why governments must step in to fund medical research and public health announcements.

Another “public good” aspect is redistribution. Many people in society feel good knowing that the poor and vulnerable are being cared for. The *act* of providing charity care can be seen as a public good that benefits everyone who values living in a compassionate society.

The ripple effect: Externalities in healthcare consumption 🔗

Finally, we come to externalities. An externality is a cost or benefit caused by a producer or consumer that is not financially incurred or received by that player. In simple terms, it’s a ripple effect on a third party.

Healthcare is packed with positive externalities. The most famous example is vaccination. When you get a vaccine, you receive a *private benefit*: you are much less likely to get sick. But you also create a massive *social benefit* for everyone around you. You are no longer a potential carrier of the disease. You won’t infect your elderly neighbor, your child’s teacher, or an immunocompromised person at the supermarket. This protection you give to others is the positive externality.

When enough people get vaccinated, it creates herd immunity, where the virus has nowhere to go and dies out, protecting even those who cannot be vaccinated. The problem? When making a decision, you (the consumer) will probably only think about your *private* benefit. You might skip the vaccine if it’s inconvenient or costs money. Because the market doesn’t capture the huge *social* benefit, the good (vaccination) will be under-consumed. This is the classic economic justification for government intervention, such as making vaccines free or even mandatory, to ensure society gets the full positive ripple effect.

It’s important to distinguish this from other gains. For example, if you receive healthcare and become healthier, you might be more productive at work. This is a *private gain* that you (and your employer) capture, not a true externality. The key is that a true externality is a tangible effect on an uninvolved third party, like not making them sick.

From economies of scale to monopoly power, and from its status as a merit good to its powerful externalities, the healthcare market is a truly unique creature. It defies the simple rules of supply and demand, forcing us to create complex systems to balance cost, access, and innovation.

What do you think? Given these many ‘market failures,’ do you believe it’s even possible for a free market to efficiently provide healthcare? Or is heavy government involvement the only viable path?

References

1. https://www.who.int/news-room/fact-sheets/detail/health-systems-financing-the-path-to-universal-coverage
2. https://nhm.gov.in/index1.php?lang=1&level=1&lid=1&sublinkid=1028
3. https://www.wto.org/english/tratop_e/trips_e/public_health_faq_e.htm
4. https://www.cdc.gov/vaccines/basics/work/protection.html